174 related articles for article (PubMed ID: 37714559)
21. Spontaneous remission of therapy-resistant minimal change nephritis in an adult woman 12 years after onset of the disease.
Raml A; Sedlak M; Schmekal B; Stuby U; Syre' G; Biesenbach G
Wien Med Wochenschr; 2006 Jul; 156(13-14):421-5. PubMed ID: 16937046
[TBL] [Abstract][Full Text] [Related]
22. Simultaneous improvement of minimal-change nephrotic syndrome and anemia with steroid therapy.
Yabana M; Kihara M; Toya Y; Tamura K; Matsumoto K; Takagi N; Kamijo S; Ishii M; Umemura S
Nephron; 1999 Jan; 81(1):84-8. PubMed ID: 9884426
[TBL] [Abstract][Full Text] [Related]
23. Comparison of methylprednisolone plus prednisolone with prednisolone alone as initial treatment in adult-onset minimal change disease: a retrospective cohort study.
Shinzawa M; Yamamoto R; Nagasawa Y; Oseto S; Mori D; Tomida K; Hayashi T; Izumi M; Fukunaga M; Yamauchi A; Tsubakihara Y; Isaka Y
Clin J Am Soc Nephrol; 2014 Jun; 9(6):1040-8. PubMed ID: 24721890
[TBL] [Abstract][Full Text] [Related]
24. A case of minimal change nephrotic syndrome with immunoglobulin A nephropathy transitioned to focal segmental glomerulosclerosis.
Hirose M; Nishino T; Uramatsu T; Obata Y; Kitamura M; Kawazu T; Miyazaki M; Taguchi T; Kohno S
Clin Exp Nephrol; 2012 Jun; 16(3):473-9. PubMed ID: 22258558
[TBL] [Abstract][Full Text] [Related]
25. Minimal change glomerulonephritis following the second dose of the Moderna COVID-19 vaccine.
Park HJ; An WS; Rha SH; Kim SE; Lee SM
QJM; 2022 Jul; 115(7):490-491. PubMed ID: 35380707
[No Abstract] [Full Text] [Related]
26. [Autoimmune hemolytic anemia following the third dose of the COVID-19 vaccine].
Ito S; Kobayashi H; Ikenouchi T; Yamamoto H; Takeuchi S; Ogawa M
Nihon Ronen Igakkai Zasshi; 2023; 60(3):283-287. PubMed ID: 37730330
[TBL] [Abstract][Full Text] [Related]
27. [Cerebral venous thrombosis in minimal change nephrotic syndrome].
Hirata M; Kuroda M; Koni I
Nihon Jinzo Gakkai Shi; 1999 Jun; 41(4):464-8. PubMed ID: 10441998
[TBL] [Abstract][Full Text] [Related]
28. Two Case Reports of Chronic Inflammatory Demyelinating Polyneuropathy After COVID-19 Vaccination.
Kim S; Lee EK; Sohn E
J Korean Med Sci; 2023 Feb; 38(8):e57. PubMed ID: 36852853
[TBL] [Abstract][Full Text] [Related]
29. A case of Miller Fisher syndrome with delayed onset peripheral facial nerve palsy after COVID-19 vaccination: a case report.
Nanatsue K; Takahashi M; Itaya S; Abe K; Inaba A
BMC Neurol; 2022 Aug; 22(1):309. PubMed ID: 35996074
[TBL] [Abstract][Full Text] [Related]
30. Nephrotic syndrome preceding Hodgkin's disease by 42 months.
Huisman RM; de Jong PE; de Zeeuw D; van Imhoff GW; van der Hem GK
Clin Nephrol; 1986 Dec; 26(6):311-3. PubMed ID: 3802598
[TBL] [Abstract][Full Text] [Related]
31. The long-term outlook to final outcome and steroid treatment results in children with idiopathic nephrotic syndrome.
Dinçel N; Yılmaz E; Kaplan Bulut İ; Hacıkara Ş; Mir S
Ren Fail; 2015; 37(8):1267-72. PubMed ID: 26313331
[TBL] [Abstract][Full Text] [Related]
32. A case of minimal change disease after the administration of anti receptor activator of nuclear factor kappa B ligand (RANKL) monoclonal antibody: a case report.
Horikoshi K; Sakai N; Yamamoto N; Ogura H; Sato K; Miyagawa T; Kitajima S; Toyama T; Hara A; Iwata Y; Shimizu M; Furuichi K; Wada T
BMC Nephrol; 2020 Sep; 21(1):416. PubMed ID: 32993539
[TBL] [Abstract][Full Text] [Related]
33. Case reports of low dose cyclosporine. A therapy in adult minimal change nephrotic syndrome.
Woo KT; Chew ST; Vathsala A; Chiang GS
Ann Acad Med Singap; 2001 Jul; 30(4):430-5. PubMed ID: 11503553
[TBL] [Abstract][Full Text] [Related]
34. [Woman with type 1 diabetes mellitus and rapidly progressive edema].
Ehren M; Dietrich JW
Dtsch Med Wochenschr; 2013 May; 138(18):940-4. PubMed ID: 23613372
[TBL] [Abstract][Full Text] [Related]
35. [Long-term follow-up study of children with minimal change nephrotic syndrome].
Takeichi S; Tazawa M; Morooka M; Minowa S; Yasaki T
Nihon Jinzo Gakkai Shi; 1997 Mar; 39(2):155-60. PubMed ID: 9134833
[TBL] [Abstract][Full Text] [Related]
36. Concurrent minimal change disease and retroperitoneal liposarcoma successfully treated by tumor resection and steroid therapy.
Yasui Y; Shibata R; Morita N; Himuro N; Hamauchi A; Watanabe M; Ito K; Yasuno T; Abe Y; Miyake K; Yoshimura F; Hamsaki M; Hisano S; Masutani K; Nakashima H
CEN Case Rep; 2021 Feb; 10(1):94-99. PubMed ID: 32902814
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
Yokoyama H; Sugiyama H; Narita I; Saito T; Yamagata K; Nishio S; Fujimoto S; Mori N; Yuzawa Y; Okuda S; Maruyama S; Sato H; Ueda Y; Makino H; Matsuo S
Clin Exp Nephrol; 2015 Jun; 19(3):496-505. PubMed ID: 25230687
[TBL] [Abstract][Full Text] [Related]
38. [A case of nephrotic syndrome associated with myasthenia gravis and malignant thymoma].
Tomida C; Yamagata K; Ishizu T; Nakajima M; Doi M; Kobayashi M; Koyama A
Nihon Jinzo Gakkai Shi; 1999 Apr; 41(2):77-82. PubMed ID: 10361423
[TBL] [Abstract][Full Text] [Related]
39. Development of hyperthyroidism in a patient with idiopathic nephrotic syndrome.
Kubota T; Hirai H; Shimizu N; Sawada A; Kondou H; Nakajima S; Harada T; Shima M
Pediatr Nephrol; 2002 May; 17(5):367-9. PubMed ID: 12042896
[TBL] [Abstract][Full Text] [Related]
40. Nephrotic syndrome associated with interferon-beta-1b therapy for multiple sclerosis.
Kumasaka R; Nakamura N; Shirato K; Fujita T; Murakami R; Shimada M; Nakamura M; Osawa H; Yamabe H; Okumura K
Clin Exp Nephrol; 2006 Sep; 10(3):222-5. PubMed ID: 17009081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]